Malta

Economic Impact Report

Our work impacts economies and healthcare systems around the world


Teva makes a positive economic impact in the countries in which we live and work. Through our spending and supply chain, we support jobs and contribute to gross domestic product (GDP). As a leading provider of generic medicines, our medicines contribute to significant healthcare savings around the world.

Based on independent analyses conducted by Matrix Global Advisors (MGA), Teva’s Global Economic Impact Report highlights Teva’s wide-ranging economic benefits and quantifies Teva’s direct and indirect economic impact in terms of jobs, labor income, GDP and generic drug savings.

   Teva's work to manufacture quality, critical treatments creates saving, supports jobs, drives economic growth. Teva's economic activity supported nearly 230000 jobs in 2018, including: 57300+ in the US, 112600+ in Europe, 19000+ in Israel, where Teva is headquartered. Our generics saved healthcare systems $55B+ in 2018, including: $42B in the US, $3B in Canada, $4B in the UK, $2B in Germany

View the full Economic Impact Report

Learn more
Nearly $55B in savings to healthcare systems across 18 countries

Explore the Key Facts and Figures Infographic

Learn more

Saving Billions While Fueling Economies

Learn more
Read more about the methodology used by Matrix Global Advisors in Teva's Global Economic Impact Report